相关实验视频

Updated: May 13, 2025

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

通过向美索林来针对感染性选择性瘤性腺病毒进行全身疗法

Mizuho Sato-Dahlman^1,2, Yoshiaki Miura¹, Praveensingh Hajeri¹

¹Department of Surgery, University of Minnesota, Minneapolis, MN, USA.

Molecular therapy. Oncology

|April 14, 2025

概括

一种新型的中素向性瘤腺病毒 (OAd) 对晚期癌症显示出有前途. 这种向的OAD改善了瘤的传递,并减少了肝脏封存,在肺癌和胰腺癌模型中显示出显著的抗瘤效应.

科学领域:

在瘤学瘤学.
病毒学病毒学
基因治疗基因治疗

背景情况:

晚期癌症需要更有效的全身疗法.
瘤性腺病毒 (OAds) 显示出抗癌潜力,但面临着传递挑战.
有针对性的传递可以克服OAds的非选择性分发和器官封存.

研究的目的:

评估用于系统性癌症治疗的中素 (MSLN) 向OAd (AdML-VTIN) 的潜力.
在表达MSLN的肺癌和胰腺癌模型中评估AdML-VTIN的生物分布,抗瘤疗效和对先前存在的免疫的抵抗力.

主要方法:

一个针对MSLN的OAd (AdML-VTIN) 的生成.
在癌症模型中静脉注射AdML-VTIN和野生型OAd (AdML-5WT).
生物分布分析,内病毒拷贝数评估和瘤生长抑制研究.
使用人血清进行中和测定,以评估先前存在的免疫力.

主要成果:

与AdML-5WT相比,AdML-VTIN表现出明显较低的肝脏封存率.
在第7天,AdML-VTIN的内病毒拷贝数显著增加.
系统性AdML-VTIN在肺癌和胰腺癌中显示出统计学上显著的抗瘤作用.
与Ad5-WT相比,AdML-VTIN对先前存在的抗体的耐药性增加,血液凝结概况发生变化.

结论:

针对MSLN的OAd (AdML-VTIN) 是一种有前途的战略,用于高级癌症的全身治疗.
针对性交付增强了OAD的有效性,并克服了与非特定分布相关的局限性.
艾德ML-VTIN具有治疗MSLN表达的肺癌和胰腺癌的潜力,即使存在先前存在的免疫.

关键词:

MT: 定期发行定期发行腺病毒纤维修饰修饰腺病毒库腺病毒库梅索林向性瘤性腺病毒科性病毒病毒.系统注射的系统注射.

更多相关视频

Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model

Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model

Published on: October 2, 2015

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines

Published on: April 21, 2022

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...